ROMVIMZA 20 mg/1
Vimseltinib · CAPSULE · Deciphera Pharmaceuticals, LLC
ROMVIMZA is a capsule containing vimseltinib at 20 mg/1, taken oral. Manufactured by Deciphera Pharmaceuticals, LLC.
Key Facts
- Brand Name
- ROMVIMZA
- Generic Name
- Vimseltinib
- NDC Code (Product)
73207-303- Manufacturer
- Deciphera Pharmaceuticals, LLC
- Strength
- 20 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA219304
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 02/14/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is ROMVIMZA used for?
ROMVIMZA contains Vimseltinib. It is a capsule taken oral. Consult your doctor for specific uses.
Is ROMVIMZA a controlled substance?
ROMVIMZA is not classified as a controlled substance by the DEA.
What is the generic name for ROMVIMZA?
The generic name for ROMVIMZA is Vimseltinib. There are no other listed brand versions of Vimseltinib.
What is the NDC code for ROMVIMZA 20 mg/1?
The NDC (National Drug Code) for ROMVIMZA 20 mg/1 is 73207-303, listed by Deciphera Pharmaceuticals, LLC.
Other ROMVIMZA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)